Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095

European Journal of Cancer

Volumn 34, Issue 5, 1998, Pages 710-717

  Miyazaki, M ^a,b   Lamharzi, N ^a   Schally, A V ^a   Halmos, G ^a   Szepeshazi, K ^a   Groot, K ^a   Cai, R Z ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin GRP antagonists; Oestrogen independent breast cancer; Tumour inhibition

Indexed keywords

BOMBESIN ANTAGONIST; GASTRIN RELEASING PEPTIDE; RC 3095; RC 3940 II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER HORMONE THERAPY; HUMAN; HUMAN TISSUE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, SOUTHERN; BOMBESIN; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, BOMBESIN; RECEPTORS, CHOLECYSTOKININ; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032055880     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10123-X     Document Type: Article

References (48)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. ÇA Cancer J Clin 1996, 65, 5-27.
2. Harris JR., Lippman ME, Veronesi U, Willett W. Breast cancer. NEnglJ Med 1992, 327, 473-480.
3. Vogel CL. Hormonal approaches to breast cancer treatment and prevention: an overview. Semin Oncol 1996, 23, 2-9.
4. Serially AV, Comaru-Schally AM. Hypothalamic and other peptide hormones. In Holland JF, Frei E III, Bast RC Jr, Kufe DE, Morton DL, Weichselbaum RR, eds. Cancer Medicine, 4th Edition. Baltimore, Williams and Wilkins, 1997, 1067-1085.
5. Santen RJ, Manni A, Harvey H, Redmond C. Endocrine treatment of breast cancer in women. Endocrine Rev 1990,11, 221-265.
6. Cuttita F, Carney DN, Mulshine JW, et al. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature (Land) 1985, 316, 823-826.
7. Radulovic S, Cai R-Z, Serfozo P, et al. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/ GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Int JPept Protein Res 1991, 38, 593-600.
8. Spindel ER, Giladi E, Segerson TP, Nagalla S. Bombesin-like peptides: of ligands and receptors. Rec Progr Hormone Res 1993, 48, 365-391.
9. Wang QJ, Knezetic JA, Schally AV, Pour PM, Adrian TE. Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. Int J Cancer 1996, 68, 17.
10. Yano T, Pinski J, Szepeshazi K, et al. Inhibitory effect of bombesin/gastrin releasing peptide (GRP) antagonist RC-3095 and LH-RH antagonist SB-75 on growth of MCF-7 Mill human breast cancer xenografts in athymic nude mice. Cancer 1994, 73, 1229-1238.
11. Shirahige Y, Cai R-Z, Szepeshazi K, et al. Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950II and RC-3095 on MCF-7 Mill human breast cancer xenografts in nude mice. Biomed Pharmacother 1994, 48, 465-472.
12. Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. J Natl Cancer Inst 1992,84, 1915-1922.
13. Halmos G, Wittliff JL, Schally AV. Characterization of bombesin/gastrin-leasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res 1995, 55, 280-287.
14. Yano T, Pinski J, Groot K, Schally AV. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992, 52, 4545-4547.
15. Cai R-Z, Qin Y, Ertl T, Schally AV. New pseudononapeptide bombesin antagonists with C-terminal Leuv|/(CH2N)Tac-NH2 show high binding affinity to bombesin/GRP receptors on CFPAC-1 human pancreatic cancer cells. Int J Oncol 1995, 6, 1165-1172.
16. Rozengurt E. Bombesin stimulation of mitogenesis; specific receptors, signal transaction, and early events. Am Rev Respir Dis 1990, 142,811-815.
17. Reile H, Cai R-Z, Armatis P, Schally AV. New antagonists of bombesin/gastrin-releasing peptide with C-terminal Leuv|/ (CH2N)Tac-NH2. Int J Oncol 1995, 7, 749-754.
18. Sethi T, Langdon S, Smyth J, Rozengurt E. Growth of small cell lung cancer cells; stimulation by multiple neuro-peptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res 1992, 52, 2737s-2742s.
19. Cai R-Z, Radulovic S, Pinski J, et al. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi. Peptides 1992, 13, 267-271.
20. Langdon S, Sethi T, Ritchie A, Muir M, Smyth J, Rozengurt E. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res 1992, 52, 4554-4557.
21. Layton JE, Scanion DB, Soveny C, Morstyn G. Effects of bombesin angonists on the growth of small cell lung cancer cells in vitro. Cancer Res 1988, 48, 4783-4789.
22. Mahmoud S, Staley J, Taylor J, et al. [Psi13'14] Bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res 1991, 51, 1798-1802.
23. Cai R-Z, Reile H, Armatis P, Schally AV. Potent bombesin antagonists with C-terminal Leuv|/(CH2N)Tac-NH2 or its derivatives. Proc NatlAcad Sei 1994, 91, 12664-12668.
24. Szepeshazi K, Schally AV, Gai R-Z, Radulovic S, Milovanovic S, Szoke B. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res 1991, 51, 5980-5986.
25. Radulovic S, Schally AV, Reile, H, et al. Inhibitory effects of antagonists of bombesin/gastrin-releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol 1994, 33, 693-701.
26. Milovanovic SR, Radulovic S, Groot K, Schally AV. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostau 1992, 20, 269-280.
27. Jungwirth A, Pinski J, Galvan G, et al. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-release hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur J Cancer 1997,33, 1147-1148.
28. Qin Y, Halmos G, Cai R-Z, Szoke B, Ertl T, Schally AV. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors. J Cancer Res Clin Oncol 1994, 200, 519-528.
29. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989,24, 148-154.
30. Chiu KY, Loke SL, Wong KK. Improved silver technique for showing nucleolar organizer regions in paraffin wax sections. J Clin Pathol 1989, 42, 992-994.
31. Szepeshazi K, Korkut E, Schally AV. Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonists and antagonist of luteinizing hormone-releasing hormone. Am J Pathol 1991, 138, 1273-1277.
32. Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immuno-binding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin EndocrinolMetab 1980, 51, 781-788.
33. Breier BR, Gallaher BW, Gluckman PD. Radio-immunoassay for insulin-like growth factor-I; solutions to some potential problems and pitfalls. J Endocrinol 1991, 128, 347-357.
34. Halmos G, Schally AM. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonists RC-3095. Proc NatlAcadSci USA 1997, 93, 956-960.
35. Halmos G, Pinski J, Szoke B, Schally AV. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer. Cancer Lett 1994,85, 111-118.
36. Munson PJ, Rodbard D. LIGAND; a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980, 107, 220-239.
37. Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. Mo/Bzo/1975, 98, 503517.
38. Steel RGD, Torrie J. Principle and Procedures of Statistics. New York, McGrawHill, 1976, 114.
39. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Serially AV. Inhibition of growth of MKN-45 human gastric adenocarcinoma xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095) and somatostatin analogue RC-160. IntJ Cancer 1994, 57, 574-580.
40. Szepeshazi K, Schally AV, Cai R-Z, Halmos G, Groot K. Effect of new bombesin antagonists given singly or in combination with a somatostatin analog on nitrosamine-induced pancreatic cancers in hamsters. IntJ Oncol 1996, 9, 397-403.
41. Qin Y, Ertl T, Cai R-Z, Horvath JE, Groot K, Schally AV. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. IntJ Cancer 1995, 63, 257-262.
42. Rozengurt E, Sinnet-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc NatlAcadSci USA 1983, 80, 2936-2940.
43. Liebow C, Crean DR, Lee MT, Kamer AR, Mang TS, Schally AV. Synergistic effects of bombesin and epidermal growth factor on cancers. Proc NatlAcadSci USA 1994, 91, 3804-3808.
44. Miller JBA, Rozengurt E. Arachidonic acid release by bombesin; a novel postreceptor target for heterologous mitogenic desensitization. J Biol Chem 1990,265, 19973-19979.
45. Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1989,1, 182-184.
46. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth factor receptors status as predictor of early recurrence and death from breast cancer. Lancet 1987, I, 1398-1402.
47. Gil J, Higgins T, Rozengurt E. Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertusis toxin-sensitive arachidonic acid release without inositol phosphate accumulation. J Cell Biol 1991, 113, 943-950.
48. Benya RV, Fathi Z, Kusui T, Pradhan T, Battey JF, Jensen RT. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. Mol Pharmacol 1994, 46, 235-245.